PTC Therapeutics | PTCT - Pe Kurs-Gewinn

Aktienkurs
68.23
Täglich Wechseln
-0.36 -0.52%
Monatlich
2.22%
Jährlich
37.75%
Q2 Prognose
66.77




Pe Veränderung Datum
Acadia Pharmaceuticals 11.61 2.09 2025-12
Alnylam Pharmaceuticals 170.7 367.33 2025-12
Amgen 25.31 15.82 2025-12
BioCryst Pharmaceuticals 6.06 1.07K 2025-12
Biogen 14.02 4.63 2025-12
BioMarin Pharmaceutical 19.24 0.21 2025-12
Daiichi Sankyo 20.73 1.74 2025-12
Esperion Therapeutics 129.79 129 2024-12
Gilead Sciences 15.63 0.08 2025-12
Incyte 14.84 2.79 2025-12
Ionis Pharmaceuticals 396.15 79.28 2022-09
Ironwood Pharmaceuticals 204.24 88.19 2024-12
Novartis 17.85 2.11 2025-12
Pfizer 14.48 5.18 2025-12
PTC Therapeutics 9.98 3.25 2025-12
Puma Biotechnology 13.93 44.88 2024-06
Roche Holding 16.09 3.51 2025-12
Sarepta Therapeutics 27.27 0 2025-09
TG Therapeutics 10.76 2.32 2025-12
Vertex Pharmaceuticals 26.15 2.22 2025-12
Xencor 29.92 3.22 2022-09